Dr. Kevin Olsen is a board-certified anesthesiologist and critical care physician whose training spans some of the nation’s premier academic medical centers, including the University of Florida, Emory University, and Harvard Medical School–affiliated Brigham and Women’s Hospital. With extensive experience managing high-acuity patients in complex perioperative and intensive care settings, he brings a unique frontline perspective to one of medicine’s most persistent and consequential risks: pulmonary aspiration.

As both a clinician and innovator, Dr. Olsen is focused on translating real-world clinical challenges into practical, scalable solutions that improve patient safety and outcomes. His work bridges bedside insight with rigorous scientific development, regulatory strategy, and commercial vision.

Aspira Therapeutics was founded under his leadership to address a large and under-recognized clinical and market opportunity in aspiration prevention. The company’s mission is to establish a new standard of care through a simple, cost-effective intervention designed for broad adoption across surgical, procedural, and critical care environments.